OBiO Technology (Shanghai) Corp., Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics 2024-08-06 11:01
OBiO Technology Officially Launched the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases 2024-05-30 21:00
OBiO Technology will showcase at American Society of Gene & Cell Therapy 2024-04-29 00:00
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product 2023-10-24 12:05
OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need. 2023-09-27 21:00
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products 2023-04-29 23:20
A new super factory with 29 GMP grade production lines for gene and cell therapy was launched in Shanghai by OBiO technology 2023-04-24 22:36
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting 2022-05-09 19:40
OBiO Technology Goes Public on Shanghai Stock Exchange Today 2022-03-22 13:00
1